Laboratorio Reig Jofre, S.A. (LON:0RB1)

Market Cap	182.48M
Revenue (ttm)	288.34M
Net Income (ttm)	3.71M
Shares Out	n/a
EPS (ttm)	0.05
PE Ratio	49.19
Forward PE	95.08
Dividend	0.03 (1.29%)
Ex-Dividend Date	May 15, 2025

Volume	112
Average Volume	542
Open	2.590
Previous Close	2.680
Day's Range	2.590 - 2.590
52-Week Range	2.500 - 3.380
Beta	0.92
RSI	34.38
Earnings Date	Feb 27, 2026

About Laboratorio Reig Jofre

Laboratorio Reig Jofre, S.A., a pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical devices, cosmetics, parapharmacy, food, and animal food. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women’s health; and food supplements und...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1929
• Employees: 1,437
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RB1

Financial Performance

In 2024, Laboratorio Reig Jofre's revenue was 341.37 million, an increase of 7.36% compared to the previous year's 317.95 million. Earnings were 10.38 million, an increase of 10.36%.

Financial numbers in EUR